» Authors » Adrien Halty

Adrien Halty

Explore the profile of Adrien Halty including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 67
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Cordoba A, Gesta E, Escande A, Noeuveglise A, Cayez R, Halty A, et al.
Front Oncol . 2024 Apr; 14:1347727. PMID: 38567146
Background And Purpose: Image-guided adapted brachytherapy (IGABT) is superior to other radiotherapy techniques in the treatment of locally advanced cervical cancer (LACC). We aimed to investigate the benefit of interstitial...
2.
Kochebina O, Halty A, Taleb J, Kryza D, Janier M, Bani Sadr A, et al.
EJNMMI Phys . 2019 Jun; 6(1):9. PMID: 31214809
Background: Gadolinium nanoparticles (Gd-NP) combined with radiotherapy are investigated for radiation dose enhancement in radiotherapy treatment. Indeed, NPs concentrated in a tumor could enhance its radiosensitization. The noninvasive quantification of...
3.
Giraudet A, Cassier P, Iwao-Fukukawa C, Garin G, Badel J, Kryza D, et al.
BMC Cancer . 2018 Jun; 18(1):646. PMID: 29884132
Background: Synovial Sarcomas (SS) are rare tumors occurring predominantly in adolescent and young adults with a dismal prognosis in advanced phases. We report a first-in-human phase I of monoclonal antibody...
4.
Halty A, Badel J, Kochebina O, Sarrut D
EJNMMI Phys . 2018 May; 5(1):11. PMID: 29766354
Background: SPECT quantification is important for dosimetry in targeted radionuclide therapy (TRT) and the calibration of SPECT images is a crucial stage for image quantification. The current standardized calibration protocol...
5.
Sarrut D, Halty A, Badel J, Ferrer L, Bardies M
Med Phys . 2017 Sep; 44(12):6280-6288. PMID: 28921613
Purpose: Estimating the biodistribution and the pharmacokinetics from time-sequence SPECT images on a per-voxel basis is useful for studying activity nonuniformity or computing absorbed dose distributions by convolution of voxel...
6.
Sarrut D, Badel J, Halty A, Garin G, Perol D, Cassier P, et al.
EJNMMI Phys . 2017 Jan; 4(1):6. PMID: 28101733
Backround: Radiolabeled OTSA101, a monoclonal antibody targeting synovial sarcoma (SS) developed by OncoTherapy Science, was used to treat relapsing SS metastases following a theranostic procedure: in case of significant In-OTSA101...